Rosuvastatin for the treatment of hyperlipidaemia in HIV-infected patients receiving protease inhibitors: a pilot study
- 1 July 2005
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 19 (10) , 1103-1105
- https://doi.org/10.1097/01.aids.0000174458.86121.43
Abstract
Sixteen HIV-infected patients with protease inhibitor (PI)-related, persisting hypercholesterolaemia were treated with 10 mg a day rosuvastatin for 24 weeks. At the end of the observation period, the median reductions in total cholesterol and triglyceride levels versus median baseline values were 21.7 and 30.1%, respectively (PKeywords
This publication has 9 references indexed in Scilit:
- Rosuvastatin is Cost-Effective in Treating Patients to Low-Density Lipoprotein-Cholesterol Goals Compared with Atorvastatin, Pravastatin and Simvastatin: Analysis of the Stellar TrialEuropean Journal of Preventive Cardiology, 2005
- Twelve-week, multicenter, randomized, open-label comparisonof the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY studyClinical Therapeutics, 2004
- Rosuvastatin in the management of hyperlipidemiaClinical Therapeutics, 2004
- Rosuvastatin-Induced Arrest in Progression of Renal DiseaseCardiology, 2004
- Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteersClinical Therapeutics, 2003
- Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials GroupClinical Infectious Diseases, 2003
- Rosuvastatin: A New HMG-CoA Reductase Inhibitor for the Treatment of HypercholesterolemiaHeart Disease, 2003
- Pharmacokinetic-Pharmacodynamic Drug Interactions with HMG-CoA Reductase InhibitorsClinical Pharmacokinetics, 2002
- Safety and Efficacy of HMG‐CoA Reductase Inhibitors for Treatment of Hyperlipidemia in Patients with HIV InfectionPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000